Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.

Ziad Bakouny,Wanling Xie,Shaan Dudani,Connor Wells,Chun Loo Gan,Frede Donskov,J Shapiro,Ian D. Davis,Francis Parnis,Praful Ravi,John A. Steinharter,Neeraj Agarwal,Ajjai Alva,Lori Wood,Anil Kapoor,José Manuel Ruiz-Morales,Christian K. Kollmannsberger,Benoit Beuselinck,Daniel Yick Chin Heng,Toni K. Choueiri

Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.

2020

608Background: The role of CN for mRCC treated with ICI is not well defined. Our aim was to evaluate the role of CN for mRCC treated by ICI or TT using a propensity score-based analysis. Methods: W...

Keywords:

Nephrectomy
Pathology
Oncology
Targeted therapy
Immune checkpoint
Propensity score matching
Renal cell carcinoma
Internal medicine
Medicine
immune checkpoint inhibitors
cytoreductive nephrectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations